Institutional Ownership
Halozyme Therapeutics Inc
CUSIP 40637HAF6NOTE 1.000% 8/1HALOQ1 2026
Dividends
Dividends-per-share are sourced from SEC XBRL filings. Either this issuer doesn't declare a common dividend, or it isn't ingested yet (we cover the top issuers first).